"As we move toward a more holistic approach to health care, integrating lifestyle modifications into clinical practice could lead to improved gastrointestinal health outcomes."
Prescribers should be aware of the risk of gallbladder and biliary tract diseases when using incretin-based drugs in patients with T2D regardless of BMI status, study shows.
The FDA warns of serious health risks associated with non-medical use of nitrous oxide, highlighting neurological damage, thromboembolic events, and death.
Reuters
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
New nonhormonal compound YCT-529 effectively and reversibly inhibits fertility in mice and nonhuman primates, and may offer potential breakthrough in male birth control options
"Although tirzepatide and semaglutide offered substantial long-term health benefits, they were not cost-effective at current net prices. Efforts to reduce the net prices of new antiobesity medications are essential to ensure equitable access to highly effective antiobesity medications."
The primary endpoint occurred in 35% of both the OMVM and placebo groups, according to a randomized trial evaluating multivitamins in post-MI patients with diabetes.
Researchers identified a J-shaped dose–response relationship, with minimal anxiety risk at six sedentary hours per day but a steep increase beyond this threshold, while walking for more than ten minutes on most days mitigated this effect.